Markets:
DJIA --55.190.16%
NASDAQ --50.190.36%
S&P -0.810.02%
Featured Stocks:
KBR +1.33% 38.99
SBUX +0.56% 113.81
DIS 0.75% 186.49
CG 0.03% 38.00

pharmaceutical stocks

  • Featured Story

    Top 7 Pharmaceutical Stocks to Buy Right Now

    By , Money Morning -

    Biotech companies are racing to develop a coronavirus vaccine. And investors are racing to profit from it. In fact, CBSNews reported on May 28 that the rush created a $200 billion stock market bubble.

    Many flocked to Gilead Sciences, Inc. (NASDAQ: GLD) after the company announced its "Remdesivir" treatment for COVID-19.

    But you don't have to follow the crowd. And you don't have to cast a mindless net over just any biotech stocks you find in the COVID-19 crisis. We're going to share with you some of the best pharma stocks to buy right now. These could be some of the most promising pharmaceuticals for coronavirus vaccine and treatment hopes.

    Read more here...

Article Index

Top 7 Pharmaceutical Stocks to Buy Right Now

By , Money Morning -

Biotech companies are racing to develop a coronavirus vaccine. And investors are racing to profit from it. In fact, CBSNews reported on May 28 that the rush created a $200 billion stock market bubble.

Many flocked to Gilead Sciences, Inc. (NASDAQ: GLD) after the company announced its "Remdesivir" treatment for COVID-19.

But you don't have to follow the crowd. And you don't have to cast a mindless net over just any biotech stocks you find in the COVID-19 crisis. We're going to share with you some of the best pharma stocks to buy right now. These could be some of the most promising pharmaceuticals for coronavirus vaccine and treatment hopes.

Read more here...

As The Markets Keep Dreaming, Listen for These Alarms

By , Global Credit Strategist, Money Morning • @MichaelELewitt -

emerging markets

Markets have no memory. So once again they are rallying based on false hopes that central bankers will save them from themselves.

Despite a stealth bear market in many stocks, the major indices have recovered all of their 2015 losses in October. They've been boosted by several factors - large cap tech stocks, expectations for a delay in Fed tightening, more European QE, and further interest rate cuts by an increasingly desperate China...Such are the stuff that dreams are made of in the terminal stages of one of the biggest bull markets in history.

As I've written before, I believe that bull market is over and we are now likely entering a bear market. There are too many macroeconomic headwinds to sustain further stock market gains.

The Chinese economic miracle is over. Commodity prices are not going to recover any time soon...

$30 Billion Deal Between Top Pharmaceutical Companies Is a Major Buy Signal

By , Associate Editor, Money Morning • @KyleAndersonMM -

Biotech Investing

Another possible deal between two of the world's top pharmaceutical companies was announced this week when Shire Plc. (Nasdaq: SHPG) made an unsolicited offer of $30.6 billion for Baxalta Inc. (NYSE: BXLT).

Money Morning Defense & Tech Specialist Michael A. Robinson has been following this trend since 2014. He knew the world's top pharmaceutical companies would continue their M&A binge, and he recommended an investment to play that wave.

Robinson's pick has already climbed 17.6% this year and still has plenty of room to run...

[Chart] Pharma Companies Make Billions as Prescription Spending Soars

By , Associate Editor, Money Morning • @KyleAndersonMM -

Biotech Investing

Prescription drug spending continues to hit record highs, and the world's top pharma companies continue to bank billions.

More than $374 billion was spent on prescription drugs in the United States in 2014, according to a report from the IMS Institute of Health. That was a 13.1% jump from 2013, and the highest growth rate in more than a decade, says ExpressScripts.

Here's a look at how U.S. prescription drug spending has trended over the last 10 years..